Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
US Army
Deloitte
Boehringer Ingelheim
McKinsey
US Department of Justice
Covington
Accenture

Generated: July 21, 2018

DrugPatentWatch Database Preview

Methacycline hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for methacycline hydrochloride and what is the scope of methacycline hydrochloride patent protection?

Methacycline hydrochloride
is the generic ingredient in one branded drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for methacycline hydrochloride.
Summary for methacycline hydrochloride
Medical Subject Heading (MeSH) Categories for methacycline hydrochloride
Synonyms for methacycline hydrochloride
(2E,4S,4aR,5S,5aR,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylene-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4AR,5S,5AR,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4-(DIMETHYLAMINO)-5,10,11,12A-TETRAHYDROXY-6-METHYLIDENE-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE
(2Z,4S,4aR,5S,5aR,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylidene-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4AR,5S,5AR,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYLIDENE-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
(4S,4aR,5S,5aR,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylidene-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
101813-12-1
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,12aS)-
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-,(4S,4aR,5S,5aR,12aS)-
2-Naphthacenecarboxamide,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride, (4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,12a.alpha.))-
2-Naphthacenecarboxamide,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,12a.alpha.)]
2-Naphthacenecarboxamide,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,12a.alpha.)]-
2507-30-4
3963-45-9
3963-95-9
3963-95-9 (mono-hydrochloride)
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
6-Demethyl-6-deoxy-5-hydroxy-6-methylenetetracycline
6-Demethyl-6-deoxy-6-methyleneoxytetracycline monohydrochloride
6-Deoxy-6-demethyl-6-methylene-5-oxytetracycline
6-Methylene-5-hydroxytetracycline
6-Methylene-5-oxytetracycline
6-Methyleneoxytetracycline
60080-37-7
8169AH
857212-11-4
914-00-1
914-00-1 (Parent)
963M959
9GJ0N7ZAP0
AB00053593_04
AB00053593_05
AB00053593-03
AB00514707
AB2000627
AC-4567
AC1L21V0
AC1NQXY8
AC1NQY0K
AC1NUHW8
Adriamicina
Adriamicina; Ciclobiotic; Germiciclin
AKOS015924655
AN-11841
API0003319
API0003320
BC205892
BDBM50103629
Bialatan
BPBio1_001065
BSPBio_000967
C07654
C08029
C22H22N2O8
C22H22N2O8.HCl
C22H23ClN2O8
CAS-3963-95-9
CCG-39016
CHEBI:6805
CHEBI:6806
CHEMBL2146123
CHEMBL249837
Ciclobiotic
CS-2560
CTK8G0821
D00849
D04972
D0H1AR
DB00931
DivK1c_000591
DSSTox_CID_25382
DSSTox_GSID_45382
DSSTox_RID_80840
DTXSID2023272
DTXSID5045382
EINECS 213-017-5
EINECS 223-568-3
FT-0082738
FT-0603654
Germiciclin
Globociclina
GS 2876
GS-2876
HMS1571A09
HMS1921D15
HSDB 3118
HY-B0449
IDI1_000591
IR235I7C5P
KBio1_000591
KBio2_000861
KBio2_003429
KBio2_005997
KBio3_001894
KBioGR_001511
KBioSS_000861
KS-1240
KSC-12-231A
KUC106428N
Londomycin
LS-93875
LS-93876
MCULE-1482268674
MCULE-8490229191
Megamycine
Metaciclina
Metaciclina [INN-Spanish]
Metacyclin hydrochloride
Metacycline
Metacycline (INN)
Metacycline hydrochloride
Metacyclinum
Metacyclinum [INN-Latin]
Metadomus
methacycline
Methacycline (hydrochloride)
Methacycline (USAN)
Methacycline [USAN:BAN]
Methacycline amphoteric
Methacycline base
Methacycline HCl
Methacycline HCl (Physiomycine)
Methacycline hydrochloride (JAN/USP)
Methacycline hydrochloride (Physiomycine)
Methacycline hydrochloride [USAN]
Methacycline hydrochloride [USP]
Methacycline hydrochloride, pharmaceutical secondary standard; traceable to USP
Methacycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Methacycline hydrochloride, VETRANAL(TM), analytical standard
Methacycline monohydrochloride
Methacyclinum
Methylenecycline
Methyleneoxytetracycline
Metilenbiotic
MHIGBKBJSQVXNH-IWVLMIASSA-N
MLS000766829
MolPort-003-666-349
MolPort-006-112-598
MolPort-006-115-821
MolPort-044-723-473
MolPort-046-033-456
MOTC
NCGC00016645-01
NCGC00179358-01
NCGC00179358-04
NINDS_000591
NSC 356465
NSC-356465
NSC-757835
NSC356465
NSC757835
Optimycin
Oxytetracycline, 6-methylene-
Pharmakon1600-01501104
Physiomycine
PL008942
PL009606
Prestwick0_000964
Prestwick1_000964
Prestwick2_000964
Prestwick3_000964
Rindex
Rondomycin
Rondomycin (TN)
s2527
SBI-0051637.P002
SC-75417
SC-76834
SCHEMBL127702
SCHEMBL19555132
SCHEMBL4014
SCHEMBL4015
SPBio_001416
SPBio_002888
Spectrum_000381
SPECTRUM1501104
Spectrum2_001398
Spectrum3_000917
Spectrum4_001016
Spectrum5_001576
STOCK1N-51719
Tox21_110542
Tox21_110542_1
Tri-methacycline
UNII-9GJ0N7ZAP0
UNII-IR235I7C5P
ZINC100017626
ZINC4019716
ZINC85650610

US Patents and Regulatory Information for methacycline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc RONDOMYCIN methacycline hydrochloride CAPSULE;ORAL 060641-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medpointe Pharm Hlc RONDOMYCIN methacycline hydrochloride CAPSULE;ORAL 060641-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medpointe Pharm Hlc RONDOMYCIN methacycline hydrochloride SYRUP;ORAL 060641-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
McKinsey
AstraZeneca
Cipla
Cerilliant
US Army
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.